Lemaitre Vascular (LMAT) Non-Current Assets (2010 - 2026)
Lemaitre Vascular's (LMAT) quarterly Non-Current Assets came in at $152.3 million in Q2 2026, up 3.25% year-over-year from $147.5 million in Q2 2025, and little changed quarter-over-quarter from $151.7 million in Q1 2026.
Analysis
Lemaitre Vascular (LMAT) Non-Current Assets (2010 - 2026) Analysis & Trends
Lemaitre Vascular (LMAT) has reported Non-Current Assets for 17 consecutive years, with $152.3 million the latest figure, recorded in Q2 2026.
- On a quarterly basis, Non-Current Assets rose 3.25% year-over-year to $152.3 million in Q2 2026; TTM through Jun 2026 was $597.5 million, a 0.43% change from a year earlier, with the FY2025 full-year figure at $147.5 million, down 1.45% from the prior year.
- Non-Current Assets was $152.3 million for Q2 2026 at Lemaitre Vascular, roughly flat from $151.7 million in the prior quarter.
- Over five years, Non-Current Assets peaked at $152.3 million in Q2 2026 and troughed at $146.0 million in Q3 2025.
- A 5-year average of $150.0 million and a median of $150.2 million in 2023 frame the typical range for Non-Current Assets.
- Across the five-year window, Non-Current Assets dropped 4.21% in 2022 and increased 3.25% in 2026, its largest moves.
- Over 5 years, Non-Current Assets stood at $148.7 million in 2022, then rose by 2.31% to $152.2 million in 2023, then slipped by 1.68% to $149.6 million in 2024, then declined by 1.45% to $147.5 million in 2025, then increased by 3.25% to $152.3 million in 2026.
- The last three Non-Current Assets figures came in at $152.3 million (Q2 2026), $151.7 million (Q1 2026), and $147.5 million (Q4 2025), per Business Quant data.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non-Current Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 179.79 Bn | 174.18 Bn | 7.27 Bn | 84.70 Bn |
| 2 | Intuitive Surgical | 127.69 Bn | 122.47 Bn | 1.96 Bn | 11.33 Bn |
| 3 | Medtronic | 117.23 Bn | 108.41 Bn | 6.34 Bn | 68.92 Bn |
| 4 | Stryker | 103.55 Bn | 100.07 Bn | 4.50 Bn | 33.51 Bn |
| 5 | Boston Scientific | 63.24 Bn | 62.70 Bn | 3.85 Bn | 37.24 Bn |
| 6 | Edwards Lifesciences | 49.97 Bn | 45.72 Bn | 1.35 Bn | 7.05 Bn |
| 7 | Alcon | 32.83 Bn | 31.37 Bn | 1.68 Bn | 24.47 Bn |
| 8 | Dexcom | 32.30 Bn | 30.35 Bn | 830.00 Mn | 2.37 Bn |
| 9 | Steris | 20.73 Bn | 20.25 Bn | 684.20 Mn | 8.29 Bn |
| 10 | Lemaitre Vascular | 1.80 Bn | 1.43 Bn | 50.76 Mn | 152.25 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 152.25 Mn |
| Mar 31, 2026 | 151.71 Mn |
| Dec 31, 2025 | 147.46 Mn |
| Sep 30, 2025 | 146.04 Mn |
| Jun 30, 2025 | 147.47 Mn |
| Mar 31, 2025 | 147.89 Mn |
| Dec 31, 2024 | 149.63 Mn |
| Sep 30, 2024 | 149.91 Mn |
| Jun 30, 2024 | 150.27 Mn |
| Mar 31, 2024 | 151.00 Mn |
| Dec 31, 2023 | 152.18 Mn |
| Sep 30, 2023 | 151.83 Mn |
| Jun 30, 2023 | 151.98 Mn |
| Mar 31, 2023 | 150.10 Mn |
| Dec 31, 2022 | 148.74 Mn |
| Sep 30, 2022 | 148.91 Mn |
| Jun 30, 2022 | 150.94 Mn |
| Mar 31, 2022 | 151.04 Mn |
| Dec 31, 2021 | 152.92 Mn |
| Sep 30, 2021 | 155.46 Mn |